Therapeutic Failure in a Renal Transplant Patient with Pneumocystis Jiroveci Pneumonia: A Case Report

Abstract

Objectives: Pneumocystis jiroveci pneumonia is common in immunocompromised individuals.

Patients: This case report describes an immuno­suppressed patient who acquired P jiroveci pneumonia 6 months after renal transplant surgery.

Results: The patient experienced many pneumonia-related complications and adverse effects from drug therapy, and despite treatment with various antibiotic agents, he died on the 62nd day after his admission to the intensive care unit.

Conclusions: The therapeutic failure of the drug of choice (co-trimoxazole) was evident.

This case raises questions about the development of P jiroveci resistance to current therapies.